FAMOTIDINE
- Product NDC
- 70518-4574
- Requested package NDC
- 70518-4574-3
- 11-digit product format
- 705184574
- Labeler code
- 70518
- Product ID
- 70518-4574_4e7dedbd-fe91-4c60-e063-6394a90aec7c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- FAMOTIDINE
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA215630
- Marketing category
- ANDA
- Marketing start
- 2026-02-16
- Substance
- FAMOTIDINE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A215630-001 | FAMOTIDINE | FAMOTIDINE | 20MG | TABLET / ORAL | AB | 2022-01-07 | |
| A215630-002 | FAMOTIDINE | FAMOTIDINE | 40MG | TABLET / ORAL | AB | 2022-01-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A215630-001 | AB |
| A215630-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A215630-001 | FAMOTIDINE | 20MG | TABLET / ORAL | AB | 2022-01-07 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A215630-002 | FAMOTIDINE | 40MG | TABLET / ORAL | AB | 2022-01-07 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A215630-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A215630-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FAMOTIDINE | FAMOTIDINE | PD-Rx Pharmaceuticals, Inc. | a0f38398-4d34-4ecc-8a6a-37732adaaad3 | 2026-07-30 | Warnings, Adverse reactions | 215630 ANDA215630 |
| FAMOTIDINE | FAMOTIDINE | HAWAII REPACK, INC. | eec89230-47fc-4139-a370-b4f9e225e8c0 | 2026-07-13 | Warnings, Adverse reactions | 215630 ANDA215630 |
| FAMOTIDINE | FAMOTIDINE | REMEDYREPACK INC. | e59a2c97-19c7-485c-bb1b-272ddb9ae053 | 2026-06-09 | Warnings, Adverse reactions | 215630 ANDA215630 |
| FAMOTIDINE | FAMOTIDINE | A-S Medication Solutions | e53928f3-5181-490b-acfb-be8d4cea60a9 | 2026-05-29 | Warnings, Adverse reactions | 215630 ANDA215630 |
| FAMOTIDINE | FAMOTIDINE | A-S Medication Solutions | 05b47b1d-f7f3-4dae-9b22-d43d2a7cfaef | 2026-05-29 | Warnings, Adverse reactions | 215630 ANDA215630 |
| FAMOTIDINE | FAMOTIDINE | ST. MARY'S MEDICAL PARK PHARMACY | febe39b1-9212-a281-e053-6394a90a1a9f | 2026-05-01 | Warnings, Adverse reactions | 215630 ANDA215630 |
| FAMOTIDINE | FAMOTIDINE | Preferred Pharmaceuticals Inc. | b445a613-eaa8-45e8-be1f-5848bfd1dd36 | 2026-04-15 | Warnings, Adverse reactions | 215630 ANDA215630 |
| FAMOTIDINE | FAMOTIDINE | Preferred Pharmaceuticals Inc. | dbf94314-3a34-4f03-80b1-296559b7d6a5 | 2026-04-15 | Warnings, Adverse reactions | 215630 ANDA215630 |
| FAMOTIDINE | FAMOTIDINE | REMEDYREPACK INC. | 3ab235f4-da59-4a92-ad6b-c76cf3ecd985 | 2026-04-02 | Warnings, Adverse reactions | 215630 ANDA215630 70518-4574-3 70518-4574 70518457403 |
| FAMOTIDINE | FAMOTIDINE | REMEDYREPACK INC. | 9c5dce17-1865-4aa6-89f6-24dd55b5f06c | 2026-01-02 | Warnings, Adverse reactions | 215630 ANDA215630 |
| FAMOTIDINE | FAMOTIDINE | A-S Medication Solutions | 74a69baa-a7c5-4e67-8db6-2ec39ab6cfe5 | 2025-12-30 | Warnings, Adverse reactions | 215630 ANDA215630 |
| FAMOTIDINE | FAMOTIDINE | Bryant Ranch Prepack | 7cef62ab-1740-4d0f-b6ea-fda783e1c197 | 2025-10-23 | Warnings, Adverse reactions | 215630 ANDA215630 |
| FAMOTIDINE | FAMOTIDINE | A-S Medication Solutions | 3c32f8e2-f54a-422d-9c25-68692ea09001 | 2025-10-10 | Warnings, Adverse reactions | 215630 ANDA215630 |
| FAMOTIDINE | FAMOTIDINE | PD-Rx Pharmaceuticals, Inc. | a3b50576-cd40-4f7e-9506-bd0a61988424 | 2025-10-09 | Warnings, Adverse reactions | 215630 ANDA215630 |
| FAMOTIDINE | FAMOTIDINE | Ascend Laboratories, LLC | be69d9f9-f4ad-4cfe-bab2-e07186b25c1e | 2025-08-07 | Warnings, Adverse reactions | 215630 ANDA215630 |
| FAMOTIDINE | FAMOTIDINE | Bryant Ranch Prepack | a24e8f45-6ace-4a81-8005-c23a55dadd9a | 2025-03-31 | Warnings, Adverse reactions | 215630 ANDA215630 |
| FAMOTIDINE | FAMOTIDINE | NuCare Pharmceuticals,Inc. | fc603d56-6828-8c5e-e053-6394a90a35bd | 2025-02-05 | Warnings, Adverse reactions | 215630 ANDA215630 |
| FAMOTIDINE | FAMOTIDINE | Bryant Ranch Prepack | 077bb160-e616-4863-bdde-989140f99e1c | 2024-08-23 | Warnings, Adverse reactions | 215630 ANDA215630 |
| FAMOTIDINE | FAMOTIDINE | NuCare Pharmaceuticals,Inc. | fd271deb-c748-bf26-e053-6294a90a11aa | 2024-06-28 | Warnings, Adverse reactions | 215630 ANDA215630 |
| FAMOTIDINE | FAMOTIDINE | Asclemed USA, Inc. | 69bd5340-298b-46ca-83c7-0b5ef233f9c5 | 2024-04-12 | Warnings, Adverse reactions | 215630 ANDA215630 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- FAMOTIDINE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| FAMOTIDINE | 20 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5QZO15J2Z8 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 310273 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3ab235f4-da59-4a92-ad6b-c76cf3ecd985 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 396bde5c-c78e-2f8b-ab1f-2ee6ba32bcae | Product name | 7 | 20260317 |
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| cf645750-2e70-f6e1-c05a-a52847def5dd | Product name | 9 | 20250312 |
| 4fdc761c-585e-054b-8ebe-86130a26e4c1 | Product name | 2 | 20221205 |
| fc2e1e31-353a-2c24-a4b4-fcf93bf7e38e | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4574-0 | FAMOTIDINE | 10 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 10 | 5 | |
| 70518-4574-1 | FAMOTIDINE | 30 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 30 | 5 | |
| 70518-4574-2 | FAMOTIDINE | 80 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 80 | 5 | |
| 70518-4574-3 | FAMOTIDINE | 60 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 60 | 5 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310273 | famotidine 20 MG Oral Tablet | PSN | 3ab235f4-da59-4a92-ad6b-c76cf3ecd985 | 5 |
| 310273 | famotidine 20 MG Oral Tablet | SCD | 3ab235f4-da59-4a92-ad6b-c76cf3ecd985 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 70518-4574-3 | 70518457403 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-4574-3) | 2026-04-02 | No | No | Current |